a.

for authorisation A_L:

1.

10 years, without prejudice to numbers 2–4,

2.⁵⁸ 5 years for biocidal products with an active substance which is a candidate for substitution, if a comparative assessment has been performed in accordance with Article 23 of Regulation (EU) No 528/2012⁵⁹,

3.

5 years for biocidal products with active substances authorised in accordance with Article 5 paragraph 2 of Regulation (EU) No 528/2012,

4.

4 years for biocidal products with an active substance which is a candidate for substitution, if no comparative assessment has been performed in accordance with Article 23 of Regulation (EU) No 528/2012;

b.

for authorisation A_nL:

1.

4 years, or

2.

if earlier, until the following time:

–

until 3 years after the last active substance in the biocidal product has been listed in Annex 1 or 2, or

–

until the Notification Authority, having regard to the European Commission’s decision not to approve the active substance or include it in Annex I to Regulation (EU) No 528/2012, cancels the authorisation;

c.

for authorisations A_N and A_C:

1.

6 months after the last active substance in the biocidal product is listed in Annex 1 or 2,

2.

3 years after the last active substance in the biocidal product is listed in Annex 1 or 2, provided that the authorisation holder meets the requirements of Article 22 paragraph 2, or

3.

until the Notification Authority, having regard to the European Commission’s decision not to approve the active substance or include it in Annex I to Regulation (EU) No 528/2012, cancels the authorisation;

d.⁶⁰

for derogations:⁶¹

1.

180 days for derogations under Article 30 paragraph 1 plus no more than 550 days if a requested extension is granted,

2.

3 years for derogations under Article 30a paragraph 1,

3.

for as long as necessary for derogations under Article 30b;

e.⁶²

for recognition:

for as long as the authorisation of the reference product is valid;

f.

for recognition of a Union authorisation:

for as long as the Union authorisation is valid;

g.

for authorisation for parallel trade:

1.

for as long as the authorisation of the reference product is valid, or

2.

if the authorisation of the reference product is withdrawn at the request of the authorisation holder and the requirements specified in Article 11 are still met: until the date on which the authorisation for the reference product would normally have expired;

h.

for the placing on the market of a biocidal product authorised under a simplified procedure in an EU or EFTA Member State:

for as long as the authorisation is valid in the EU or EFTA Member State;

i.

for the placing on the market of a product within a biocidal product family:

for as long as the authorisation for the biocidal product family is valid;

j.

for release for purposes of research and development:

for the declared test duration;

k.⁶³

for simplified authorisation:

10 years;

l.⁶⁴

for the authorisation of the same biocidal products:

1.

– 10 years for authorisations based on an ordinary authorisation Z_L,

–

5 years for authorisations based on an authorisation Z_L with an active substance that is a candidate for substitution, or

–

4 years for authorisations based on an authorisation Z_L with an active substance authorised under Article 5 paragraph 2 of Regulation (EU) 528/2012,

2.

10 years for biocidal products whose authorisation is based on a recognition or a recognition of a Union authorisation,

3.

for as long as the term of authorisation for the reference product applies for biocidal products whose authorisation is based on an authorisation Z_N or Z_B.